Isolated central hypothyroidism: Underlying pathophysiology and relation to antidepressant and antipsychotic medications—A multi‐centre South Wales study
Authors' conclusion
Our study strongly suggests isolated central hypothyroidism, in the absence of other pituitary hormone dysfunction or visual field defect, does not require further investigation, saving resources as well as sparing patients unnecessary anxiety. It also strongly supports a relationship between patients taking psychotropic medications and biochemical isolated central hypothyroidism, an association only described in a very limited amount of literature before this, and further supporting our previous single-centre study findings. The mechanism behind this is likely to be the suppression of thyrotropin secretion via antagonism of the dopamine-serotoninergic pathway. In our opinion, patients found to have isolated biochemical central hypothyroidism who are taking psychotropic medications can therefore be regarded to have a recognised cause for this biochemical finding and do not require further radiological investigation.
Study context
- Population
- Patients referred to endocrinology with unexplained isolated biochemical central hypothyroidism, nine hospitals in South Wales, over a 6-year period1,022 screened
- Participants
- 71 patients
- Outcome
- Final diagnosis (pathophysiology) of isolated central hypothyroidism; clinically significant pathology on pituitary imaging
Methodological detailsmulticentre, nine hospitals
- Multicentre
- Nine hospitals
Main finding
As reported in the abstract
Patients with clinically significant pathology on pituitary imaging
0 of 71
Observational data: associations, not effects.
Further findings
- Patients taking psychotropic medications
- 46/71 (65%)
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →